-
- Service Offerings
- Managed Market Analysis
- Education and Training
- Competitive Intelligence
- Expanded Access
- Case Studies
- Comparative Effectiveness Review - Diabetes
- Expanded Access
- Comparative Cost Analysis - Pharmaceuticals
- Healthcare Reform Analysis
- Health Technology Assessment - Oncology
- Reimbursement Call Center and Patient Assistance Program Design - Multiple Product Classes
- Reimbursement Training and Field Reimbursement Call Tracking Tool
- Competitive Intelligence - Urology
- Product Commercialization and Reimbursement Landscape Analysis - Oncology
- Clinical Services Evaluation - Specialty Pharmacy
- Commercialization Strategy - Deep Vein Thrombosis
- Coverage Analysis - Drug Delivery System
- Reimbursement Coverage and Coding Analysis - Vascular Stents
- Health Economic Analysis - Rheumatoid Arthritis
- Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
- Comprehensive Clinical Analysis and Clinical Protocol Design - Migrane
- Outcomes Research Plan - Gastroenterology
- Clinical Compendium and Gap Analysis - Pain Management
- Reimbursement Landscape Analysis - Rare Bleeding Disorders (Hemophilia)
- Disease Area Review and Burden of Illness Analysis - Oncology
- Hospital Inpatient Payor Claims Analysis - Hospital Acquired Infections
- Health Economic Analysis - Orthopedics
- Market Valuation - Opioids
- Meta Analysis - HIV (Human Immunodeficiency Virus)
- AMCP Dossier - Dermatology
- Competitive Intelligence - Infectious Diseases
- Competitive Intelligence - Contraception
- Reimbursement Landscape Analysis - Urology
- Health Economics Analysis - Crohn's Disease
- Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
- Patient Assistance Program Design - Insulin Products
- Health Technology Assessment - Wound Therapy System
Case Studies
Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
Insight
A leader in vascular analysis technology created a diagnostic product for neurovascular disease and hoped to spur product adoption and diffusion by demonstrating value through a comprehensive reimbursement strategy and health economic analysis.
Strategy
The Aequitas Group designed a reimbursement strategy that aligned with the requirements of the Centers for Medicare and Medicaid Services (CMS) and commercial payors for making coverage determinations for technology adoption. In addition to creating a reimbursement roadmap strategy, The Aequitas Group also prepared a product valuation report, composed of a financial model that projected revenues through a 10 year time span and then discounted these revenues to create a current valuation for the client’s product. Our research team conducted primary market research with former medical directors from national health plans, in order to evaluate existing coverage guidelines and define opportunities.
Execution
The deliverable provided strategies for action in the event of either a positive or negative decision from the insurers.
© 2009 The Aequitas Group, Inc. All Rights Reserved.